OGT’s Popular ESHG Workshop Free to View Online
News Jul 17, 2015
Oxford Gene Technology (OGT) has made its European Human Genetics (ESHG) Conference workshop freely available to view online. The presentation, entitled “The Next Generation of Microarrays: Identifying a Broader Range of Genetic Syndromes Using Exon-Focussed Array Designs”, took place at the ESHG conference in Glasgow, UK on 8th June 2015. OGT also launched its CytoSure™ Constitutional v3 Arrays at the event.
Having become one of the premier events in the field of human genetics, ESHG is a forum for all workers in human and medical genetics to review the latest advances and develop research collaborations.
OGT’s workshop was one of the best attended workshops of the conference, with over 150 delegates turning up to learn how OGT has coupled its microarray design expertise with the latest developmental disorder content to create CytoSure Constitutional v3 arrays.
Launched at the ESHG conference, these are the only arrays available with enhanced content from the Deciphering Developmental Disorders (DDD) study and ClinGen (formerly ISCA/ICCG) - enabling high-resolution CNV detection across ~500 genes of interest.
Senior Computational Biologist at OGT, Duarte Molha, discussed OGT’s advanced microarray design strategies to deliver the latest generation of exon-focused arrays for the accurate detection of small DNA deletions and duplications.
In addition, Professor Madhuri Hegde PhD, FACMG, Professor of Human Genetics at Emory University School of Medicine presented how Emory University complements its next generation sequencing workflows with OGT’s CytoSure Medical Research Exome array to provide gold-standard CNV detection at the exon level. Visitors to OGT’s website can now experience the complete workshop.
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.